drugset / Trial / NCT02777788
Curative Study of Chinese Traditional Medicine to Treat Lung Cancer
Phase 2/3
Unknown
120 enrolled
Shanghai University of Traditional Chinese Medicine
Shanghai Chest Hospital · collabShanghai Pulmonary Hospital, Shanghai, China · collab
RandomizedParallel-groupOpen-labelSupportive care
Summary
The purpose of this study is to observe the efficacy of chemotherapy combined with Chinese patent drugs for patients with advanced non-small-cell lung cancer, also to evaluate the adverse reaction and the reliability.
Timeline
- Start
- 2014-09
- Primary completion
- 2019-12
- Completion
- 2019-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | JinFuKang | Traditional medicine (herbal / TCM) | 30 ml | Oral |
| Subject | XingZaoRuanJian | Traditional medicine (herbal / TCM) | 30 ml | Oral |
| Comparator | Carboplatin | Small molecule | 5 unknown | Intravenous |
| Comparator | Cisplatin | Other / unclassified | 75 mg/m2 | Intravenous |
| Comparator | Docetaxel | Small molecule | 75 mg/m2 | Intravenous |
| Comparator | Gemcitabine | Small molecule | 1250 mg/m2 | Intravenous |
| Comparator | Nedaplatin | Small molecule | 80 mg/m2 | Intravenous |
| Comparator | Paclitaxel | Small molecule | 175 mg/m2 | Intravenous |
| Comparator | Pemetrexed | Small molecule | 500 mg/m2 | Intravenous |
| Comparator | Vinorelbine | Small molecule | 25 mg/m2 | Intravenous |